WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007011904) RECOMBINANT FLU VACCINES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/011904    International Application No.:    PCT/US2006/027764
Publication Date: 25.01.2007 International Filing Date: 19.07.2006
IPC:
A61K 39/145 (2006.01)
Applicants: DOW GLOBAL TECHNOLOGIES INC. [US/US]; Washington Street, 1790 Building, Midland, MI 48674 (US) (For All Designated States Except US).
RASOCHOVA, Lada [US/US]; (US) (For US Only).
RADAM, Jason, M. [US/US]; (US) (For US Only).
PHELPS, Jamie, P. [US/US]; (US) (For US Only).
DANG, Nghiep [US/US]; (US) (For US Only)
Inventors: RASOCHOVA, Lada; (US).
RADAM, Jason, M.; (US).
PHELPS, Jamie, P.; (US).
DANG, Nghiep; (US)
Agent: BELLOWS, Brent, R.; KING & SPALDING LLP, 1180 Peachtree Street, NE, 34th Floor, Atlanta, GA 30309-3521 (US)
Priority Data:
60/700,601 19.07.2005 US
Title (EN) RECOMBINANT FLU VACCINES
(FR) VACCINS RECOMBINANTS CONTRE LA GRIPPE
Abstract: front page image
(EN)The present invention provides compositions for use as vaccines against the influenza virus, and rapid methods of producing such compositions. The composition include i) at least one peptide derived from an influenza virus, wherein the peptide is fused to a capsid protein derived from a plant virus forming a recombinant capsid fusion peptide and ii) at least one isolated antigenic protein or protein fragment derived from a human or avian influenza virus. The isolated antigenic protein or protein fragment derived from the human or avian influenza virus can be conjugated to the surface of the recombinant capsid fusion peptide.
(FR)La présente invention concerne des compositions à utiliser comme vaccins contre le virus grippal, et des procédés rapides de production de telles compositions. Cette composition contient i) au moins un peptide dérivé du virus grippal, ce peptide étant fixé à une protéine de capside dérivée d'un virus de plante formant un peptide de fusion de capside recombinant et ii) au moins une protéine antigénique isolée ou un fragment protéique dérivé(e) d'un virus de grippe humaine ou aviaire. La protéine antigénique isolée ou le fragment protéique dérivé(e) du virus de la grippe humaine ou aviaire peut être conjugué à la surface du peptide de fusion de capside recombinant.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)